Quality Control and Evaluation in Standard COPD Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

210 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is lack of quality control and evaluation indexes for standard COPD management in hospitals in China, leading to nonstandard in COPD management and discrepancy in therapeutic efficiency. This study focuses on establishing quality control and evaluation indexes for standard COPD management in hospitals in China, and evaluating the therapeutic efficiency after standard COPD management. This part is a prospective cohort which lasts 2 years. After standard COPD management according to GOLD 2017 by doctors in hospitals in China, patients will be followed up for their outcome after 1 year. Several indexes will be selected to evaluate the quality control of standard COPD management and its efficiency. The controls are from hospital-based subjects with a retrospective cohort study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Evaluation of COPD Butler in Patient Home Management

NCT03471091

COPD Hypercapnic Respiratory Failure

UNKNOWN NA

Effect of Traditional Chinese Medicine on Outcomes in COPD Patients

NCT03007914

Pulmonary Disease, Chronic Obstructive

UNKNOWN

Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD

NCT06063733

Pulmonary Disease, Chronic Obstructive

UNKNOWN NA

China Chronic Obstructive Pulmonary Disease Registration Research

NCT02929537

Pulmonary Disease, Chronic Obstructive

UNKNOWN

Impact of Multi-Component Interventions on High Risk COPD Population

NCT06456996

Multimorbidity Population Medicine Chronic Obstructive Pulmonary Disease

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard managed subjects

COPD patients accepted standard COPD management.

GOLD 2017

Intervention Type OTHER

Standard COPD management according to GOLD 2017, and control the quality of management in one-year follow-up.

Controls

COPD patients didn't accepted standard COPD management or quality control, who are from hospital subjects with a retrospective cohort study.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GOLD 2017

Standard COPD management according to GOLD 2017, and control the quality of management in one-year follow-up.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.Clinical manifestation of COPD; post bronchodilator FEV1/FVC\<0.70

Exclusion Criteria

* 1\. lung cancer. 2. Any history of psychiatric disorders. 3.HIV positive. 4.Breastfeeding, pregnancy or planning to be pregnant. 5.Estimated lifetime less than 1 years due to underlying diseases.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No